These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
2851 |
|
||||||||||||
|
(State or other jurisdiction of
incorporation or organization) |
(Primary Standard Industrial
Classification Code Number) |
(I.R.S. Employer
Identification No.) |
||||||||||||
|
|
|
|
||||||||||||
| (Title of class) | (Trading symbol) | (Exchange on which registered) | ||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of goods sold |
|
|
|
|
||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||
| Other operating (benefits) charges |
(
|
|
|
|
||||||||||||||||||||||
| Research and development expenses |
|
|
|
|
||||||||||||||||||||||
| Amortization of acquired intangibles |
|
|
|
|
||||||||||||||||||||||
| Income (loss) from operations |
|
(
|
|
|
||||||||||||||||||||||
| Interest expense, net |
|
|
|
|
||||||||||||||||||||||
| Other income, net |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Income (loss) before income taxes |
|
(
|
|
(
|
||||||||||||||||||||||
| Provision (benefit) for income taxes |
|
(
|
|
(
|
||||||||||||||||||||||
| Net income (loss) |
|
(
|
|
(
|
||||||||||||||||||||||
| Less: Net (loss) income attributable to noncontrolling interests |
|
(
|
|
(
|
||||||||||||||||||||||
| Net income (loss) attributable to controlling interests | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| Basic net income (loss) per share | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| Diluted net income (loss) per share | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
| Net income (loss) | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| Other comprehensive income (loss), before tax: | ||||||||||||||||||||||||||
| Foreign currency translation adjustments |
|
|
|
(
|
||||||||||||||||||||||
| Unrealized gain (loss) on derivatives |
|
(
|
|
(
|
||||||||||||||||||||||
| Unrealized gain on pension and other benefit plan obligations |
|
|
|
|
||||||||||||||||||||||
| Other comprehensive income (loss), before tax |
|
|
|
(
|
||||||||||||||||||||||
| Income tax provision (benefit) related to items of other comprehensive income (loss) |
|
(
|
|
(
|
||||||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
|
|
(
|
||||||||||||||||||||||
| Comprehensive income (loss) |
|
(
|
|
(
|
||||||||||||||||||||||
| Less: Comprehensive income (loss) attributable to noncontrolling interests |
|
|
|
(
|
||||||||||||||||||||||
| Comprehensive income (loss) attributable to controlling interests | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| June 30, 2021 | December 31, 2020 | |||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Restricted cash |
|
|
||||||||||||
| Accounts and notes receivable, net |
|
|
||||||||||||
| Inventories |
|
|
||||||||||||
| Prepaid expenses and other current assets |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Property, plant and equipment, net |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Identifiable intangibles, net |
|
|
||||||||||||
| Other assets |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| Liabilities, Shareholders’ Equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Current portion of borrowings |
|
|
||||||||||||
| Other accrued liabilities |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term borrowings |
|
|
||||||||||||
| Accrued pensions |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Other liabilities |
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
| Commitments and contingent liabilities (Note 5) |
|
|
||||||||||||
| Shareholders’ equity: | ||||||||||||||
|
Common shares, $
|
|
|
||||||||||||
| Capital in excess of par |
|
|
||||||||||||
| Retained earnings |
|
|
||||||||||||
|
Treasury shares, at cost,
|
(
|
(
|
||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
| Total Axalta shareholders’ equity |
|
|
||||||||||||
| Noncontrolling interests |
|
|
||||||||||||
| Total shareholders’ equity |
|
|
||||||||||||
| Total liabilities and shareholders’ equity | $ |
|
$ |
|
||||||||||
| Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Comprehensive loss: | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — |
|
|
|||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized gain on derivatives, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Total comprehensive loss | — | — | — |
|
— |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
(
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Common stock purchases |
(
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||
| Dividends declared to noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2021 |
|
|
|
|
(
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — |
|
|
|||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized gain on derivatives, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Total comprehensive income | — | — | — |
|
— |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Common stock purchases |
(
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2019 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — |
|
|
|||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized loss on derivatives, net of tax benefit of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Total comprehensive loss | — | — | — |
|
— |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Cumulative effect of an accounting change | — | — | — |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
(
|
— | — | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||
| Ownership changes relating to noncontrolling interests | — | — |
|
— | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Dividends declared to noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2020 |
|
|
|
|
(
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
(
|
— | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized loss on derivatives, net of tax benefit of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax benefit of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | — | — | — |
(
|
— |
|
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Changes in redeemable noncontrolling interests | — | — |
(
|
— | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Common stock purchases | — | — | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Six Months Ended June 30, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| Operating activities: | ||||||||||||||
| Net income (loss) | $ |
|
$ |
(
|
||||||||||
| Adjustment to reconcile net income (loss) to cash provided by operating activities: | ||||||||||||||
| Depreciation and amortization |
|
|
||||||||||||
| Amortization of deferred financing costs and original issue discount |
|
|
||||||||||||
| Debt extinguishment and refinancing related costs |
|
|
||||||||||||
| Deferred income taxes |
|
(
|
||||||||||||
| Realized and unrealized foreign exchange losses, net |
|
|
||||||||||||
| Stock-based compensation |
|
|
||||||||||||
| Divestiture and impairment charges |
|
|
||||||||||||
| Interest income on swaps designated as net investment hedges |
(
|
(
|
||||||||||||
| Other non-cash, net |
|
|
||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||
| Trade accounts and notes receivable |
(
|
|
||||||||||||
| Inventories |
(
|
|
||||||||||||
| Prepaid expenses and other assets |
(
|
(
|
||||||||||||
| Accounts payable |
|
(
|
||||||||||||
| Other accrued liabilities |
|
(
|
||||||||||||
| Other liabilities |
|
|
||||||||||||
| Cash provided by (used for) operating activities |
|
(
|
||||||||||||
| Investing activities: | ||||||||||||||
| Acquisitions, net of cash acquired |
(
|
|
||||||||||||
| Purchase of property, plant and equipment |
(
|
(
|
||||||||||||
| Interest proceeds on swaps designated as net investment hedges |
|
|
||||||||||||
| Other investing activities, net |
(
|
|
||||||||||||
| Cash used for investing activities |
(
|
(
|
||||||||||||
| Financing activities: | ||||||||||||||
| Proceeds from long-term borrowings |
|
|
||||||||||||
| Payments on short-term borrowings |
(
|
(
|
||||||||||||
| Payments on long-term borrowings |
(
|
(
|
||||||||||||
| Financing-related costs |
(
|
(
|
||||||||||||
| Purchases of common stock |
(
|
(
|
||||||||||||
| Net cash flows associated with stock-based awards |
|
|
||||||||||||
| Purchase of noncontrolling interests |
|
(
|
||||||||||||
| Other financing activities, net |
(
|
(
|
||||||||||||
| Cash (used for) provided by financing activities |
(
|
|
||||||||||||
| (Decrease) increase in cash |
(
|
|
||||||||||||
| Effect of exchange rate changes on cash |
(
|
(
|
||||||||||||
| Cash at beginning of period |
|
|
||||||||||||
| Cash at end of period | $ |
|
$ |
|
||||||||||
| Cash at end of period reconciliation: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Restricted cash |
|
|
||||||||||||
| Cash at end of period | $ |
|
$ |
|
||||||||||
| Note | Page | |||||||
|
Performance
Coatings |
Mobility
Coatings |
Total | ||||||||||||||||||
| Balance at December 31, 2020 | $ |
|
$ |
|
$ |
|
||||||||||||||
| Goodwill from acquisitions |
|
|
|
|||||||||||||||||
| Foreign currency translation |
(
|
(
|
(
|
|||||||||||||||||
| Balance at June 30, 2021 | $ |
|
$ |
|
$ |
|
||||||||||||||
| June 30, 2021 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted average
amortization periods (years) |
||||||||||||||||||||||
| Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
| Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
| Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
| Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
| Other |
|
(
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
||||||||||||||||||||
| December 31, 2020 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted average
amortization periods (years) |
||||||||||||||||||||||
| Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
| Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
| Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
| Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
| Other |
|
(
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
||||||||||||||||||||
| Remainder of 2021 | $ |
|
||||||
| 2022 |
|
|||||||
| 2023 |
|
|||||||
| 2024 |
|
|||||||
| 2025 |
|
|||||||
| 2026 |
|
|||||||
| 2021 Activity | ||||||||
| Balance at December 31, 2020 | $ |
|
||||||
| Expenses, net of changes to estimates |
|
|||||||
| Payments made |
(
|
|||||||
| Foreign currency translation |
(
|
|||||||
| Balance at June 30, 2021 | $ |
|
||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
|
Components of net periodic benefit cost:
|
||||||||||||||||||||||||||
| Net periodic benefit cost: | ||||||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Interest cost |
|
|
|
|
||||||||||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Amortization of actuarial loss, net |
|
|
|
|
||||||||||||||||||||||
| Plan curtailments |
|
(
|
|
(
|
||||||||||||||||||||||
| Net periodic benefit cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Stock Options |
Awards
(in millions) |
Weighted-
Average Exercise Price |
Aggregate
Intrinsic Value (in millions) |
Weighted
Average Remaining Contractual Life (years) |
||||||||||||||||||||||
| Outstanding at January 1, 2021 |
|
$ |
|
|||||||||||||||||||||||
| Granted |
|
$ |
|
|||||||||||||||||||||||
| Exercised |
(
|
$ |
|
|||||||||||||||||||||||
| Forfeited / Expired |
(
|
$ |
|
|||||||||||||||||||||||
| Outstanding at June 30, 2021 |
|
$ |
|
|||||||||||||||||||||||
| Vested and expected to vest at June 30, 2021 |
|
$ |
|
$ |
|
|
||||||||||||||||||||
| Exercisable at June 30, 2021 |
|
$ |
|
$ |
|
|
||||||||||||||||||||
|
Restricted Stock Awards and Restricted Stock Units
(1)
|
Awards/Units
(millions) |
Weighted-Average
Fair Value |
||||||||||||
| Outstanding at January 1, 2021 |
|
$ |
|
|||||||||||
| Granted |
|
$ |
|
|||||||||||
| Vested |
(
|
$ |
|
|||||||||||
| Forfeited |
(
|
$ |
|
|||||||||||
| Outstanding at June 30, 2021 |
|
$ |
|
|||||||||||
|
Performance Stock Awards and Performance Share Units
(1)
|
Awards/Units
(millions) |
Weighted-Average
Fair Value |
||||||||||||
| Outstanding at January 1, 2021 |
|
$ |
|
|||||||||||
| Granted |
|
$ |
|
|||||||||||
| Vested |
|
$ |
|
|||||||||||
| Forfeited |
(
|
$ |
|
|||||||||||
| Outstanding at June 30, 2021 |
|
$ |
|
|||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
| Foreign exchange losses (gains), net | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
| Debt extinguishment and refinancing related costs |
|
|
|
|
||||||||||||||||||||||
|
Other miscellaneous income, net
(1)
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Total | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Six Months Ended June 30, | ||||||||||||||
| 2021 | 2020 | |||||||||||||
| Effective Tax Rate |
|
% |
|
% | ||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| (In millions, except per share data) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Net income (loss) to common shareholders | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| Basic weighted average shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Diluted weighted average shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Net income (loss) per common share: | ||||||||||||||||||||||||||
| Basic net income (loss) per share | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| Diluted net income (loss) per share | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| June 30, 2021 | December 31, 2020 | |||||||||||||
|
Accounts receivable - trade, net
(1)
|
$ |
|
$ |
|
||||||||||
| Notes receivable |
|
|
||||||||||||
|
Other
(2)
|
|
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
| June 30, 2021 | December 31, 2020 | |||||||||||||
| Finished products | $ |
|
$ |
|
||||||||||
| Semi-finished products |
|
|
||||||||||||
| Raw materials |
|
|
||||||||||||
| Stores and supplies |
|
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
| June 30, 2021 | December 31, 2020 | |||||||||||||
| Property, plant and equipment | $ |
|
$ |
|
||||||||||
| Accumulated depreciation |
(
|
(
|
||||||||||||
| Property, plant, and equipment, net | $ |
|
$ |
|
||||||||||
| June 30, 2021 | December 31, 2020 | |||||||||||||
| 2024 Dollar Term Loans | $ |
|
$ |
|
||||||||||
| 2025 Euro Senior Notes |
|
|
||||||||||||
| 2027 Dollar Senior Notes |
|
|
||||||||||||
| 2029 Dollar Senior Notes |
|
|
||||||||||||
| Short-term and other borrowings |
|
|
||||||||||||
| Unamortized original issue discount |
(
|
(
|
||||||||||||
| Unamortized deferred financing costs |
(
|
(
|
||||||||||||
| Total borrowings, net |
|
|
||||||||||||
| Less: | ||||||||||||||
| Short-term borrowings |
|
|
||||||||||||
| Current portion of long-term borrowings |
|
|
||||||||||||
| Long-term debt | $ |
|
$ |
|
||||||||||
| Remainder of 2021 | $ |
|
||||||
| 2022 |
|
|||||||
| 2023 |
|
|||||||
| 2024 |
|
|||||||
| 2025 |
|
|||||||
| Thereafter |
|
|||||||
| Total borrowings |
|
|||||||
| Unamortized original issue discount |
(
|
|||||||
| Unamortized deferred financing costs |
(
|
|||||||
| Total borrowings, net | $ |
|
||||||
| June 30, 2021 | December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid expenses and other current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(2)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| Other assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Investments in equity securities
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Other accrued liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Interest rate caps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Interest rate swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Contingent consideration
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Other liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Interest rate swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(2)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Contingent consideration
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Long-term borrowings: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 2024 Dollar Term Loans |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| 2025 Euro Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| 2027 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| 2029 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Fair Value Using Significant Unobservable Inputs
(Level 3) |
||||||||
| Beginning balance January 1, 2021 | $ |
|
||||||
| Activity |
|
|||||||
| Ending balance at March 31, 2021 |
|
|||||||
| Business acquisition |
|
|||||||
| Ending balance at June 30, 2021 | $ |
|
||||||
| June 30, 2021 | December 31, 2020 | |||||||||||||
| AOCI: | ||||||||||||||
| Interest rate caps (cash flow hedges) | $ |
|
$ |
|
||||||||||
| Interest rate swaps (cash flow hedges) |
|
|
||||||||||||
| Foreign currency forward contracts (cash flow hedges) |
|
|
||||||||||||
| Cross-currency swaps (net investment hedges) |
|
|
||||||||||||
| Total AOCI | $ |
|
$ |
|
||||||||||
| For the Three Months Ended June 30, | ||||||||||||||||||||||||||||||||
| 2021 | 2020 | |||||||||||||||||||||||||||||||
| Derivatives in Cash Flow and Net Investment Hedges | Location of Loss (Gain) Recognized in Income on Derivatives | Net Amount of Loss (Gain) Recognized in OCI on Derivatives | Amount of Loss (Gain) Recognized in Income | Net Amount of Loss (Gain) Recognized in OCI on Derivatives | Amount of Loss (Gain) Recognized in Income | |||||||||||||||||||||||||||
| Interest rate caps | Interest expense, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Interest rate swaps | Interest expense, net |
|
|
|
|
|||||||||||||||||||||||||||
|
Foreign currency forward contracts
(1)
|
Cost of goods sold |
|
|
|
|
|||||||||||||||||||||||||||
|
Cross-currency swaps
|
Interest expense, net |
(
|
(
|
|
(
|
|||||||||||||||||||||||||||
| For the Six Months Ended June 30, | ||||||||||||||||||||||||||||||||
| 2021 | 2020 | |||||||||||||||||||||||||||||||
| Derivatives in Cash Flow and Net Investment Hedges | Location of Loss (Gain) Recognized in Income on Derivatives | Net Amount of (Gain) Recognized in OCI on Derivatives | Amount of Loss (Gain) Recognized in Income | Net Amount of Loss (Gain) Recognized in OCI on Derivatives | Amount of Loss (Gain) Recognized in Income | |||||||||||||||||||||||||||
| Interest rate caps | Interest expense, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Interest rate swaps | Interest expense, net |
(
|
|
|
|
|||||||||||||||||||||||||||
|
Foreign currency forward contracts
(1)
|
Cost of goods sold |
|
|
|
|
|||||||||||||||||||||||||||
|
Cross-currency swaps
|
Interest expense, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
|
Derivatives Not Designated as Hedging
Instruments under ASC 815 |
Location of Gain (Loss) Recognized in
Income (Loss) on Derivatives |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||||||||
| Foreign currency forward contracts | Other income, net | $ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
|
Net sales
(1)
:
|
||||||||||||||||||||||||||
| Refinish | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Industrial |
|
|
|
|
||||||||||||||||||||||
| Total Net sales Performance Coatings |
|
|
|
|
||||||||||||||||||||||
| Light Vehicle |
|
|
|
|
||||||||||||||||||||||
| Commercial Vehicle |
|
|
|
|
||||||||||||||||||||||
| Total Net sales Mobility Coatings |
|
|
|
|
||||||||||||||||||||||
| Total Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
|
Segment Adjusted EBIT
(1)
:
|
||||||||||||||||||||||||||
| Performance Coatings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Mobility Coatings |
|
(
|
|
(
|
||||||||||||||||||||||
|
Total
(2)
|
|
(
|
|
|
||||||||||||||||||||||
| Interest expense, net |
|
|
|
|
||||||||||||||||||||||
|
Debt extinguishment and refinancing related costs
(a)
|
|
|
|
|
||||||||||||||||||||||
|
Termination benefits and other employee related costs
(b)
|
|
|
|
|
||||||||||||||||||||||
|
Strategic review and retention costs
(c)
|
|
|
|
|
||||||||||||||||||||||
|
Offering and transactional costs
(d)
|
|
|
|
|
||||||||||||||||||||||
|
Impairment charges
(e)
|
|
|
|
|
||||||||||||||||||||||
|
Pension special events
(f)
|
|
(
|
|
(
|
||||||||||||||||||||||
|
Accelerated depreciation
(g)
|
|
|
|
|
||||||||||||||||||||||
|
Indemnity income
(h)
|
(
|
|
(
|
|
||||||||||||||||||||||
|
Operational matter
(i)
|
(
|
|
|
|
||||||||||||||||||||||
|
Brazil indirect tax
(j)
|
(
|
|
(
|
|
||||||||||||||||||||||
| Income (loss) before income taxes | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| (1) | The primary measure of segment operating performance is Adjusted EBIT, which is defined as net income before interest, taxes and select other items impacting operating results. These other items impacting operating results are items that management has concluded are (1) non-cash items included within net income, (2) items the Company does not believe are indicative of ongoing operating performance or (3) non-recurring, unusual or infrequent items that have not occurred within the last two years or we believe are not reasonably likely to recur within the next two years. Adjusted EBIT is a key metric that is used by management to evaluate business performance in comparison to budgets, forecasts and prior year financial results, providing a measure that management believes reflects the Company’s core operating performance, which represents Adjusted EBIT adjusted for the select items referred to above. | ||||
| (2) |
Does not represent Axalta’s Adjusted EBIT referenced elsewhere by the Company as there are additional adjustments that are not allocated to the segments.
|
||||
| (a) | Represents expenses and associated changes to estimates related to the prepayment, restructuring, and refinancing of our indebtedness, which are not considered indicative of our ongoing operating performance. | ||||
| (b) | Represents expenses and associated changes to estimates related to employee termination benefits and other employee-related costs. Employee termination benefits are primarily associated with Axalta Way initiatives. These amounts are not considered indicative of our ongoing operating performance. | ||||
| (c) |
Represents costs for legal, tax and other advisory fees pertaining to our review of strategic alternatives that was concluded in March 2020, as well as retention awards for certain employees which will be earned over a period of
|
||||
| (d) | Represents acquisition and divestiture-related expenses, all of which are not considered indicative of our ongoing operating performance. | ||||
| (e) | Represents impairment charges, which are not considered indicative of our ongoing performance. | ||||
| (f) | Represents certain defined benefit pension costs associated with special events, including pension curtailments, settlements and special termination benefits, which we do not consider indicative of our ongoing operating performance. | ||||
| (g) | Represents incremental depreciation expense resulting from truncated useful lives of the assets impacted by our manufacturing footprint assessments, which we do not consider indicative of our ongoing operating performance. | ||||
| (h) | Represents indemnity income associated with acquisitions, which we do not consider indicative of our ongoing operating performance. | ||||
| (i) | Represents expenses, changes in estimates and insurance recoveries for probable liabilities related to an operational matter in the Mobility Coatings segment discussed further in Note 5, which is not indicative of our ongoing operating performance. | ||||
| (j) | Represents non-recurring income related to a law change with respect to certain Brazilian indirect taxes which was recorded within other income, net. | ||||
|
Unrealized
Currency Translation Adjustments |
Pension
Adjustments |
Unrealized
(Loss) Gain on Derivatives |
Accumulated
Other Comprehensive (Loss) Income |
|||||||||||||||||||||||
| Balance at December 31, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Current year deferrals to AOCI |
(
|
|
|
(
|
||||||||||||||||||||||
| Reclassifications from AOCI to Net income |
|
|
|
|
||||||||||||||||||||||
| Net Change |
(
|
|
|
(
|
||||||||||||||||||||||
| Balance at March 31, 2021 |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Current year deferrals to AOCI |
|
|
(
|
|
||||||||||||||||||||||
| Reclassifications from AOCI to Net income |
|
|
|
|
||||||||||||||||||||||
| Net Change |
|
|
|
|
||||||||||||||||||||||
| Balance at June 30, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
|
Unrealized
Currency Translation Adjustments |
Pension
Adjustments |
Unrealized
Gain (Loss) on Derivatives |
Accumulated
Other Comprehensive Income (Loss) |
|||||||||||||||||||||||
| Balance at December 31, 2019 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Current year deferrals to AOCI |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Reclassifications from AOCI to Net loss |
|
(
|
|
|
||||||||||||||||||||||
| Net Change |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Balance at March 31, 2020 |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Current year deferrals to AOCI |
|
|
(
|
|
||||||||||||||||||||||
| Reclassifications from AOCI to Net loss |
|
|
|
|
||||||||||||||||||||||
| Net Change |
|
|
(
|
|
||||||||||||||||||||||
| Balance at June 30, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| (In millions) | Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | ||||||||||||||||||||||||||||||||||
| 2021 | 2020 | % change | 2021 | 2020 | % change | |||||||||||||||||||||||||||||||||
| Performance Coatings | ||||||||||||||||||||||||||||||||||||||
| Refinish | $ | 463.1 | $ | 261.9 | 76.8 | % | $ | 862.1 | $ | 629.7 | 36.9 | % | ||||||||||||||||||||||||||
| Industrial | 342.7 | 220.2 | 55.6 | % | 651.0 | 500.1 | 30.2 | % | ||||||||||||||||||||||||||||||
| Total Net sales Performance Coatings | 805.8 | 482.1 | 67.1 | % | 1,513.1 | 1,129.8 | 33.9 | % | ||||||||||||||||||||||||||||||
| Mobility Coatings | ||||||||||||||||||||||||||||||||||||||
| Light Vehicle | 243.9 | 126.3 | 93.1 | % | 522.8 | 386.4 | 35.3 | % | ||||||||||||||||||||||||||||||
| Commercial Vehicle | 77.1 | 44.3 | 74.0 | % | 154.5 | 120.0 | 28.8 | % | ||||||||||||||||||||||||||||||
| Total Net sales Mobility Coatings | 321.0 | 170.6 | 88.2 | % | 677.3 | 506.4 | 33.7 | % | ||||||||||||||||||||||||||||||
| Total Net sales | $ | 1,126.8 | $ | 652.7 | 72.6 | % | $ | 2,190.4 | $ | 1,636.2 | 33.9 | % | ||||||||||||||||||||||||||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
|
Net sales
|
$ | 1,126.8 | $ | 652.7 | $ | 474.1 | 72.6 | % | $ | 2,190.4 | $ | 1,636.2 | $ | 554.2 | 33.9 | % | ||||||||||||||||||||||||||||||||||
|
Volume effect
|
56.4 | % | 25.3 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| Impact of acquisitions | 1.6 | % | 0.6 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| Price/Mix effect | 9.3 | % | 3.9 | % | ||||||||||||||||||||||||||||||||||||||||||||||
|
Exchange rate effect
|
5.3 | % | 4.1 | % | ||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales increased due to the following:
|
||
|
n
Higher sales volumes across both segments as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Higher average selling price driven by Performance Coatings as a result of pricing actions in both end-markets and improved product mix in Refinish
|
||
|
n
Favorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Net sales increased due to the following:
|
||
|
n
Higher sales volumes across both segments as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Favorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
n
Higher average selling price driven by Performance Coatings as a result of pricing actions in both end-markets and improved product mix in Refinish
|
||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
| Cost of sales | $ | 752.8 | $ | 499.2 | $ | 253.6 | 50.8 | % | $ | 1,437.3 | $ | 1,146.0 | $ | 291.3 | 25.4 | % | ||||||||||||||||||||||||||||||||||
|
% of net sales
|
66.8 | % | 76.5 | % | 65.6 | % | 70.0 | % | ||||||||||||||||||||||||||||||||||||||||||
|
Cost of sales increased due to the following:
|
||
|
n
Higher sales volumes across both segments as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Higher variable input costs due to raw material inflation
|
||
|
n
Increased compensation related expenses compared to prior year which were lower due to COVID-19 related cost reduction actions
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Partially offset by:
|
||
|
n
Reduction in costs due to operational efficiencies associated with our cost savings initiatives
|
||
|
n
Decreased expenses of $31.1 million associated with improved utilization at manufacturing sites in the current year as manufacturing utilization was negatively impacted in the 2020 period due to COVID-19
|
||
|
n
Lower expenses in 2021 compared to 2020 of $5.2 million resulting from fewer inventory write-offs
|
||
|
Cost of sales as a percentage of net sales decreased due to the following:
|
||
|
n
Higher sales volume covering fixed costs
|
||
|
n
Decreases in costs due to operational efficiencies associated with cost savings initiatives
|
||
| Partially offset by: | ||
|
n
Higher variable input costs due to raw material inflation
|
||
|
Cost of sales increased due to the following:
|
||
|
n
Higher sales volumes across both segments as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Higher variable input costs due to raw material inflation
|
||
|
n
Increased compensation related expenses compared to prior year which were lower due to COVID-19 related cost reduction actions
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Partially offset by:
|
||
|
n
Reduction in costs due to operational efficiencies associated with our cost savings initiatives
|
||
|
n
Decreased expenses of $35.2 million associated with improved utilization at manufacturing sites in the current year as manufacturing utilization was negatively impacted in the 2020 period due to COVID-19
|
||
|
n
Lower expenses in 2021 compared to 2020 of $7.3 million resulting from fewer inventory write-offs
|
||
|
Cost of sales as a percentage of net sales decreased due to the following:
|
||
|
n
Higher sales volume covering fixed costs
|
||
|
n
Decreases in costs due to operational efficiencies associated with cost savings initiatives
|
||
| Partially offset by: | ||
|
n
Higher variable input costs due to raw material inflation
|
||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
|
SG&A
|
$ | 184.2 | $ | 154.2 | $ | 30.0 | 19.5 | % | $ | 363.3 | $ | 349.6 | $ | 13.7 | 3.9 | % | ||||||||||||||||||||||||||||||||||
|
Selling, general and administrative expenses increased due to the following:
|
||
|
n
Increase in commissions and sales incentive compensation driven by increased sales
|
||
|
n
Increased expenses as a result of acquisitions
|
||
|
n
Increased compensation related expenses compared to prior year which were lower due to COVID-19 related cost reduction actions
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Partially offset by:
|
||
|
n
Lower expenses in 2021 compared to 2020 of $6.8 million resulting from fewer inventory write-offs
|
||
|
Selling, general and administrative expenses increased due to the following:
|
||
|
n
Increase in commissions and sales incentive compensation driven by increased sales
|
||
|
n
Increased expenses as a result of acquisitions
|
||
|
n
Increased compensation related expenses compared to prior year which were lower due to COVID-19 related cost reduction actions
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Partially offset by:
|
||
|
n
Reduction in costs due to operational efficiencies associated with our cost savings initiatives
|
||
|
n
Lower expenses in 2021 compared to 2020 of $9.5 million resulting from fewer inventory write-offs
|
||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
| Other operating (benefits) charges | $ | (45.7) | $ | 24.7 | $ | (70.4) | (285.0) | % | $ | 57.1 | $ | 56.3 | $ | 0.8 | 1.4 | % | ||||||||||||||||||||||||||||||||||
|
Other operating (benefits) charges decreased due to the following:
|
||
|
n
Benefits of $71.8 million in the current year related to insurance recoveries and changes to our estimates for probable liabilities in for an operational matter in our Mobility Coatings segment discussed further in Note 5 to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q
|
||
|
n
Expenses of $4.5 million associated with the review of strategic alternatives that was concluded in March 2020, with no such expenses in 2021
|
||
|
n
Impairment charges of $2.7 million in the prior year primarily related to impairments and associated write-downs resulting from our decision to exit the Performance Coatings segment business in Argentina, compared with no such expenses in 2021
|
||
|
Partially offset by:
|
||
|
n
Increase of $7.5 million in termination benefits and other employee related costs associated with our cost saving initiatives from $15.2 million in the prior year to $22.7 million in the current year
|
||
|
Other operating (benefits) charges increased due to the following:
|
||
|
n
Expenses of $22.6 million in the current year as a result of a charge recorded in relation to probable liabilities for an operational matter in our Mobility Coatings segment discussed further in Note 5 to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q
|
||
|
Partially offset by:
|
||
|
n
Expenses of $10.6 million associated with the review of strategic alternatives that was concluded in March 2020, with no such expenses in 2021
|
||
|
n
Decrease of $9.2 million in termination benefits and other employee related costs associated with our cost saving initiatives from $34.7 million in the prior year to $25.5 million in the current year
|
||
|
n
Impairment charges of $3.2 million in the prior year primarily related to impairments and associated write-downs resulting from our decision to exit the Performance Coatings segment business in Argentina, compared with no such expenses in 2021
|
||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
|
Research and development expenses
|
$ | 15.8 | $ | 11.2 | $ | 4.6 | 41.1 | % | $ | 31.4 | $ | 27.8 | $ | 3.6 | 12.9 | % | ||||||||||||||||||||||||||||||||||
|
Research and development expenses increased due to the following:
|
||
|
n
Increase in compensation related expenses and other spending as a result of temporary cost savings initiatives during 2020
|
||
|
Research and development expenses increased due to the following:
|
||
|
n
Increase in compensation related expenses and other spending as a result of temporary cost savings initiatives during 2020
|
||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
|
Amortization of acquired intangibles
|
$ | 29.3 | $ | 27.9 | $ | 1.4 | 5.0 | % | $ | 58.3 | $ | 55.9 | $ | 2.4 | 4.3 | % | ||||||||||||||||||||||||||||||||||
|
Amortization of acquired intangibles increased due to the following:
|
||
|
n
Unfavorable impacts of foreign currency translation, primarily related to fluctuations of the Euro compared to the U.S. dollar
|
||
|
Amortization of acquired intangibles increased due to the following:
|
||
|
n
Unfavorable impacts of foreign currency translation, primarily related to fluctuations of the Euro compared to the U.S. dollar
|
||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
| Interest expense, net | $ | 33.4 | $ | 36.1 | $ | (2.7) | (7.5) | % | $ | 66.9 | $ | 72.6 | $ | (5.7) | (7.9) | % | ||||||||||||||||||||||||||||||||||
|
Interest expense, net decreased primarily due to the following:
|
||
|
n
Decrease in interest rates due to LIBOR decreases on our variable rate debt over the comparable period
|
||
|
Partially offset by:
|
||
|
n
Unfavorable impacts of our derivative instruments used to hedge the variable interest rate exposure on certain debt arrangements
|
||
|
Interest expense, net decreased primarily due to the following:
|
||
|
n
Decrease in interest rates due to LIBOR decreases on our variable rate debt over the comparable period
|
||
|
Partially offset by:
|
||
|
n
Unfavorable impacts of our derivative instruments used to hedge the variable interest rate exposure on certain debt arrangements
|
||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
| Other income, net | $ | (8.1) | $ | (2.2) | $ | (5.9) | 268.2 | % | $ | (8.5) | $ | (1.4) | $ | (7.1) | 507.1 | % | ||||||||||||||||||||||||||||||||||
|
Other income, net increased due to the following:
|
||
|
n
Income of $8.3 million recorded in 2021 related to a law change with respect to certain Brazilian indirect taxes
|
||
|
Partially offset by:
|
||
|
n
Unfavorable impact of foreign exchange losses of $2.1 million when compared with the prior year period
|
||
|
Other income, net changed due to the following:
|
||
|
n
Income of $8.3 million recorded in 2021 related to a law change with respect to certain Brazilian indirect taxes
|
||
|
n
Reduction in debt extinguishment and refinancing related costs of $2.2 million
|
||
|
Partially offset by:
|
||
|
n
Unfavorable impact of foreign exchange losses of $1.6 million when compared with the prior year period
|
||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
| Income (loss) before income taxes | $ | 165.1 | $ | (98.4) | $ | 184.6 | $ | (70.6) | ||||||||||||||||||
| Provision (benefit) for income taxes | 38.7 | (15.2) | 42.5 | (39.8) | ||||||||||||||||||||||
|
Statutory U.S. Federal income tax rate
|
21.0 | % | 21.0 | % | 21.0 | % | 21.0 | % | ||||||||||||||||||
|
Effective tax rate
|
23.4 | % | 15.4 | % | 23.0 | % | 56.4 | % | ||||||||||||||||||
| Effective tax rate vs. statutory U.S. Federal income tax rate | 2.4 | % | (5.6) | % | 2.0 | % | 35.4 | % | ||||||||||||||||||
| (Favorable) Unfavorable Impact | ||||||||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
|
Items impacting the effective tax rate vs. statutory U.S. federal income tax rate
|
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
|
Earnings generated in jurisdictions where the statutory rate is different from the U.S. Federal rate
(1)
|
$ | (2.3) | $ | (1.6) | $ | (7.0) | $ | (5.9) | ||||||||||||||||||
|
Changes in valuation allowance
|
5.4 | 2.1 | 12.4 | (2.4) | ||||||||||||||||||||||
| Foreign exchange gain (loss), net | 1.0 | — | (0.6) | 8.5 | ||||||||||||||||||||||
|
Non-deductible expenses and interest
|
1.3 | 1.8 | 2.1 | 3.1 | ||||||||||||||||||||||
|
Increase in unrecognized tax benefits
(2)
|
1.4 | 1.4 | 3.7 | 19.3 | ||||||||||||||||||||||
|
Intra-entity asset transfer
(3)
|
— | — | — | (50.5) | ||||||||||||||||||||||
| Foreign taxes | 1.9 | 1.9 | 3.3 | 3.5 | ||||||||||||||||||||||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
|
Net sales
|
$ | 805.8 | $ | 482.1 | $ | 323.7 | 67.1 | % | $ | 1,513.1 | $ | 1,129.8 | $ | 383.3 | 33.9 | % | ||||||||||||||||||||||||||||||||||
|
Volume effect
|
45.5 | % | 23.0 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| Impact of acquisitions | 2.1 | % | 0.9 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| Price/Mix effect | 14.0 | % | 5.3 | % | ||||||||||||||||||||||||||||||||||||||||||||||
|
Exchange rate effect
|
5.5 | % | 4.7 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT | $ | 139.7 | $ | 1.5 | $ | 138.2 | 9,213.3 | % | $ | 256.9 | $ | 80.9 | $ | 176.0 | 217.6 | % | ||||||||||||||||||||||||||||||||||
|
Adjusted EBIT Margin
|
17.3 | % | 0.3 | % | 17.0 | % | 7.2 | % | ||||||||||||||||||||||||||||||||||||||||||
|
Net sales increased due to the following:
|
||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Higher average selling prices and product mix across both end-markets, driven by price actions within both end-markets and improved product mix in Refinish North America
|
||
|
n
Favorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Adjusted EBIT increased due to the following:
|
||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Lower manufacturing expenses compared to the prior year as a result of underutilized manufacturing assets in the prior year quarter due to COVID-19 demand impacts
|
||
|
n
Higher average selling prices and product mix across both end-markets and most regions
|
||
|
Partially offset by:
|
||
|
n
Higher variable input costs across both end-markets and all regions due to raw material inflation
|
||
|
n
Higher operating expenses across both end-markets driven by EMEA and North America as a result of temporary cost savings initiatives during 2020
|
||
| Adjusted EBIT margins increased during the three months ended June 30, 2021 due to the following: | ||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Lower manufacturing expenses compared to the prior year as a result of underutilized manufacturing assets in the prior year quarter due to COVID-19 demand impacts
|
||
|
n
Higher average selling prices and product mix across both end-markets and most regions
|
||
| Partially offset by: | ||
|
n
Higher variable input costs across both end-markets and all regions due to raw material inflation
|
||
|
Net sales increased due to the following:
|
||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Higher average selling prices and product mix across both end-markets, driven by price actions within both end-markets and improved product mix in Refinish North America
|
||
|
n
Favorable impacts of currency translation, due primarily to the fluctuations of the Euro, Chinese Renminbi, and British Pound compared to the U.S. dollar
|
||
|
Adjusted EBIT increased due to the following:
|
||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Lower manufacturing expenses compared to the prior year as a result of underutilized manufacturing assets in the prior year quarter due to COVID-19 demand impacts
|
||
|
n
Higher average selling prices and product mix across both end-markets and most regions
|
||
|
n
Lower operating expenses across most regions resulting from operational efficiencies associated with our cost savings initiatives
|
||
|
Partially offset by:
|
||
|
n
Higher variable input costs across both end-markets and all regions due to raw material inflation
|
||
| Adjusted EBIT margins increased during the six months ended June 30, 2021 due to the following: | ||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Lower manufacturing expenses compared to the prior year as a result of underutilized manufacturing assets in the prior year quarter due to COVID-19 demand impacts
|
||
|
n
Higher average selling prices and product mix across both end-markets and most regions
|
||
| Partially offset by: | ||
|
n
Higher variable input costs across both end-markets and all regions due to raw material inflation
|
||
| Three Months Ended June 30, | 2021 vs 2020 | Six Months Ended June 30, | 2021 vs 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | $ Change | % Change | 2021 | 2020 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 321.0 | $ | 170.6 | $ | 150.4 | 88.2 | % | $ | 677.3 | $ | 506.4 | $ | 170.9 | 33.7 | % | ||||||||||||||||||||||||||||||||||
| Volume effect | 87.4 | % | 30.5 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| Price/Mix effect | (4.1) | % | 0.7 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| Exchange rate effect | 4.9 | % | 2.5 | % | ||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT | $ | 5.7 | $ | (39.3) | $ | 45.0 | 114.5 | % | $ | 44.9 | $ | (13.5) | $ | 58.4 | 432.6 | % | ||||||||||||||||||||||||||||||||||
| Adjusted EBIT Margin | 1.8 | % | (23.0) | % | 6.6 | % | (2.7) | % | ||||||||||||||||||||||||||||||||||||||||||
|
Net sales increased due to the following:
|
||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Favorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Partially offset by:
|
||
|
n
Lower average selling prices and product mix driven by Light Vehicle in our Latin America and Asia Pacific regions
|
||
|
Adjusted EBIT increased due to the following:
|
||
|
n
Higher volumes across both end-markets across all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Lower manufacturing expenses compared to the prior year as a result of underutilized manufacturing assets in the prior year quarter due to COVID-19 demand impacts
|
||
|
n
Lower operating expenses across most regions resulting from operational efficiencies associated with our cost savings initiatives
|
||
|
Partially offset by:
|
||
|
n
Higher variable input costs due to raw material inflation
|
||
|
n
Lower average selling prices and product mix driven by Light Vehicle in our Latin America and Asia Pacific regions
|
||
| Adjusted EBIT margins increased during the three months ended June 30, 2021 due to the following: | ||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Lower manufacturing expenses compared to the prior year as a result of underutilized manufacturing assets in the prior year quarter due to COVID-19 demand impacts
|
||
|
n
Lower operating expenses across most regions resulting from operational efficiencies associated with our cost savings initiatives
|
||
| Partially offset by: | ||
|
n
Higher variable input costs due to raw material inflation
|
||
|
Net sales increased due to the following:
|
||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Favorable impacts of currency translation, due primarily to the fluctuations of the Euro and Chinese Renminbi, partially offset by the weakening of the Brazilian Real, compared to the U.S. dollar
|
||
|
Adjusted EBIT increased due to the following:
|
||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Lower manufacturing expenses compared to the prior year as a result of underutilized manufacturing assets in the prior year quarter due to COVID-19 demand impacts
|
||
|
n
Lower operating expenses across all regions resulting from operational efficiencies associated with our cost savings initiatives
|
||
|
Partially offset by:
|
||
|
n
Higher variable input costs due to raw material inflation
|
||
| Adjusted EBIT margins increased during the six months ended June 30, 2021 due to the following: | ||
|
n
Higher volumes across both end-markets and all regions as a result of demand recovery from the impacts of COVID-19
|
||
|
n
Lower manufacturing expenses compared to the prior year as a result of underutilized manufacturing assets in the prior year quarter due to COVID-19 demand impacts
|
||
|
n
Lower operating expenses across all regions resulting from operational efficiencies associated with our cost savings initiatives
|
||
| Partially offset by: | ||
|
n
Higher variable input costs due to raw material inflation
|
||
| Six Months Ended June 30, | ||||||||||||||
| (In millions) | 2021 | 2020 | ||||||||||||
| Net cash provided by (used for): | ||||||||||||||
| Operating activities: | ||||||||||||||
| Net income (loss) | $ | 142.1 | $ | (30.8) | ||||||||||
| Depreciation and amortization | 155.4 | 163.2 | ||||||||||||
| Amortization of deferred financing costs and original issue discount | 4.2 | 4.1 | ||||||||||||
| Debt extinguishment and refinancing related costs | 0.2 | 2.4 | ||||||||||||
| Deferred income taxes | 5.2 | (61.2) | ||||||||||||
| Realized and unrealized foreign exchange losses, net | 9.4 | 2.8 | ||||||||||||
| Stock-based compensation | 7.8 | 11.2 | ||||||||||||
| Divestiture and impairment charges | — | 3.2 | ||||||||||||
| Interest income on swaps designated as net investment hedges | (7.1) | (7.3) | ||||||||||||
| Other non-cash, net | 9.2 | 8.3 | ||||||||||||
| Net income adjusted for non-cash items | 326.4 | 95.9 | ||||||||||||
| Changes in operating assets and liabilities | (179.3) | (98.4) | ||||||||||||
| Operating activities | 147.1 | (2.5) | ||||||||||||
| Investing activities | (91.3) | (34.3) | ||||||||||||
| Financing activities | (169.9) | 159.1 | ||||||||||||
| Effect of exchange rate changes on cash | (8.4) | (16.3) | ||||||||||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | $ | (122.5) | $ | 106.0 | ||||||||||
| (In millions) | June 30, 2021 | December 31, 2020 | ||||||||||||
| 2024 Dollar Term Loans | $ | 2,051.0 | $ | 2,063.2 | ||||||||||
| 2025 Euro Senior Notes | 535.8 | 552.1 | ||||||||||||
| 2027 Dollar Senior Notes | 500.0 | 500.0 | ||||||||||||
| 2029 Dollar Senior Notes | 700.0 | 700.0 | ||||||||||||
| Short-term and other borrowings | 103.0 | 118.0 | ||||||||||||
| Unamortized original issue discount | (5.5) | (6.3) | ||||||||||||
| Unamortized deferred financing costs | (30.4) | (34.3) | ||||||||||||
| Total borrowings, net | 3,853.9 | 3,892.7 | ||||||||||||
| Less: | ||||||||||||||
| Short-term borrowings | 16.2 | 29.9 | ||||||||||||
| Current portion of long-term borrowings | 24.3 | 24.3 | ||||||||||||
| Long-term debt | $ | 3,813.4 | $ | 3,838.5 | ||||||||||
| (in millions, except per share data) | ||||||||||||||||||||||||||
| Month |
Total Number of Shares Purchased
(1)
|
Average Price Paid per Share
(1)
|
Total Number of Shares Purchased as Part of Publicly Announced Programs
(1)
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program
(1)(2)
|
||||||||||||||||||||||
| April 2021 | — | $ | — | — | $ | 797.5 | ||||||||||||||||||||
| May 2021 | 0.5 | 32.32 | 0.5 | 782.5 | ||||||||||||||||||||||
| June 2021 | 1.4 | 31.54 | 1.4 | 737.5 | ||||||||||||||||||||||
| Total | 1.9 | $ | 31.73 | 1.9 | $ | 737.5 | ||||||||||||||||||||
|
EXHIBIT NO.
|
DESCRIPTION OF EXHIBITS
|
||||
| 10.4* | |||||
| 31.1 | |||||
| 31.2 | |||||
| 32.1† | |||||
| 32.2† | |||||
| 101 | INS - Inline XBRL Instance Document. The document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document | ||||
| 101 | SCH - Inline XBRL Taxonomy Extension Schema Document | ||||
| 101 | CAL - Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101 | DEF - Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101 | LAB - Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101 | PRE - Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
| * | Previously filed. | ||||
| † | This certificate is being furnished solely to accompany the report pursuant to 18 U.S.C. Section 1350 and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. | ||||
| AXALTA COATING SYSTEMS LTD. | |||||||||||
| Date: | July 26, 2021 | By: /s/ Robert W. Bryant | |||||||||
| Robert W. Bryant | |||||||||||
| Chief Executive Officer and President | |||||||||||
| (Principal Executive Officer) | |||||||||||
| Date: | July 26, 2021 | By: /s/ Sean M. Lannon | |||||||||
| Sean M. Lannon | |||||||||||
| Senior Vice President and Chief Financial Officer | |||||||||||
| (Principal Financial Officer) | |||||||||||
| Date: | July 26, 2021 | By: /s/ Anthony Massey | |||||||||
| Anthony Massey | |||||||||||
| Vice President and Global Controller | |||||||||||
| (Principal Accounting Officer) | |||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Snap-on Incorporated | SNA |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|